These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 2935415

  • 1. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT, Appel JB.
    Eur J Pharmacol; 1986 Dec 02; 132(1):87-91. PubMed ID: 2949989
    [Abstract] [Full Text] [Related]

  • 3. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 02; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov 02; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB, Goldberg LI, Woolverton WL.
    J Pharmacol Exp Ther; 1987 Sep 02; 242(3):804-11. PubMed ID: 2958620
    [Abstract] [Full Text] [Related]

  • 6. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.
    Barrett RL, Appel JB.
    Psychopharmacology (Berl); 1989 Sep 02; 99(1):13-6. PubMed ID: 2528777
    [Abstract] [Full Text] [Related]

  • 7. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE, Woolverton WL.
    Pharmacol Biochem Behav; 1990 Oct 02; 37(2):289-93. PubMed ID: 1981936
    [Abstract] [Full Text] [Related]

  • 8. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 9. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.
    Callahan PM, Appel JB, Cunningham KA.
    Psychopharmacology (Berl); 1991 May 28; 103(1):50-5. PubMed ID: 2006243
    [Abstract] [Full Text] [Related]

  • 11. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
    Schechter MD, Greer NL.
    Life Sci; 1987 Jun 22; 40(25):2461-71. PubMed ID: 2953944
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE, Sutherland JV, Woolverton WL.
    Behav Neural Biol; 1990 May 22; 53(3):378-92. PubMed ID: 1972014
    [Abstract] [Full Text] [Related]

  • 13. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM, Sheridan RD, Szabadi E.
    Br J Pharmacol; 1985 Oct 22; 86(2):483-90. PubMed ID: 2932196
    [Abstract] [Full Text] [Related]

  • 14. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 22; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 22; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 16. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 22; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 17. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
    Cory-Slechta DA, Widzowski DV.
    Brain Res; 1991 Jul 05; 553(1):65-74. PubMed ID: 1681979
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM, Wiederhold KH.
    Brain Res; 1985 Feb 18; 327(1-2):390-4. PubMed ID: 3157422
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS, Robertson HA.
    Brain Res; 1986 Oct 08; 384(2):387-90. PubMed ID: 2946360
    [Abstract] [Full Text] [Related]

  • 20. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M, Fenu S, Di Chiara G.
    Life Sci; 1987 Jan 19; 40(3):245-51. PubMed ID: 2948094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.